Clinical trial

A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets

NCT05660863

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2027-09-01

PhasePHASE1

Study timeline

Study start (estimated)2027-09-01Date precision: day

Registry last updated2026-09-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Arterial Hypertensionunresolved

Interventions

MN-08 24 mg/dayDRUG

MN-08 60 mg/dayDRUG

Sponsors & collaborators

Guangzhou Magpie Pharmaceuticals Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05660863 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.